Saturday 17 October 2026
Export FEMY’s income statement to Excel — free account
Femasys Inc.
FEMY Healthcare Medical Instruments & Supplies
Femasys Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.3 million, up 40.8% from fiscal 2024. In the quarter to June 2026, revenue fell 18.9%, EPS grew 58.4%, free cash flow grew 11.3% and total debt rose 3,369.3%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
1.65
0.09
−5.17%
Follow FEMY
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
3 | 3 | 2 | 3 |
+8 more TTM periods Free account |
| (443.65%) | (267.10%) | (455.80%) | (376.23%) | ||
| (94.25%) | (83.31%) | (112.32%) | (124.24%) | ||
ROIC |
(176.91%) | (175.17%) | (578.36%) | (12,042.89%) | |
Return on Tangible Assets |
(194.88%) | (111.61%) | (126.58%) | (573.23%) | |
Average Days of Receivables |
23.97 | 26.46 | 98.13 | 101.31 | |
Free Cash Flow per Share |
(5.38) | (5.57) | (9.72) | (9.79) | |
Free Cash Flow |
(18.07) | (18.58) | (19.22) | (20.07) | |
Capital Expenditures |
(0.42) | (0.51) | (0.52) | (0.49) | |
| Other line items | |||||
Cash ROIC |
(198.78%) | (111.86%) | (94.04%) | (217.47%) | |
Accounts Receivable Turnover |
11.34 | 11.71 | 4.15 | 4.34 | |
Accounts Payable Turnover |
0.32 | 0.47 | 0.54 | 0.46 | |
Inventory Turnover |
0.16 | 0.18 | 0.20 | 0.20 | |
Average Days of Payables |
950.16 | 638.20 | 765.69 | 1,041.71 | |
Days of Inventory on Hand |
2,516.79 | 2,438.91 | 2,401.62 | 2,771.64 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
280.54% | 248.99% | 330.41% | 384.73% | |
Selling, General and Administrative Expense of Revenue |
529.69% | 486.18% | 483.55% | 519.87% | |
Share Based Compensation of Revenue |
26.24% | 24.17% | 34.45% | 41.61% | |
Interest Coverage |
(13.48) | (10.17) | (9.30) | (9.20) | |
Operating CF/Net income |
1.44 | 1.46 | 1.00 | 0.99 | |
Depreciation/Fixed assets |
(0.03) | 0.08 | 0.18 | 0.19 | |
Capex/Depreciation |
8.79 | (3.19) | (1.54) | (1.45) | |
Revenue per Share |
0.69 | 0.71 | 1.16 | 1.01 | |
Operating CF per Share |
(5.26) | (5.42) | (9.45) | (9.55) | |
Capex per Share |
(0.13) | (0.15) | (0.27) | (0.24) | |
Capex to Sales |
0.18 | 0.21 | 0.23 | 0.24 |
Columns are period end dates